Chronic, treatment-resistant depression and right fronto-striatal atrophy
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Treatment-resistant depression (TRD) is relatively common but its neurobiological basis is poorly understood. Fronto-striatal structural brain changes have been reported in patients with depression but their association with treatment resistance and chronicity has not been established. Method: Magnetic resonance images of 20 patients with TRD were compared with images of 20recovered patients and 20 healthy controls. Images were compared using a voxel-based analysis (VBA) method; the results were validated by conventional volumetric analysis. The clinical associations of magnetic resonance imaging (MRI) changes with illness duration and severity were examined by VBA. Results: Only the TRD group exhibited right fronto-striatal atrophy, and subtle MRI changes in the left hippocampus on VBA. Atrophy was confirmed on volumetric analysis, the degree correlating with the cumulative number of electroconvulsive therapy (ECT) treatments received, suggesting an acquired deficit. Conclusions: This is the first study to demonstrate fronto-striatal atrophy in patients with depression with poor outcome; the atrophy is more marked in those with more severe illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Limbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
Long-term Outcome of Episodes of Major Depression: Clinical and Public Health Significance
Keller, M. B. (1984) · JAMA · doi:10.1001/jama.252.6.788 · Cited by 295
A magnetic resonance imaging study of putamen nuclei in major depression
Husain, M. M., McDonald, W. M., Doraiswamy, P. M., Figiel, G. S., Na, C., Escalona, P. R., Boyko, O. B., Nemeroff, C. B., & Krishnan, K. R. R. (1991) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(91)90001-7 · Cited by 256
Clinical and psychometric correlates of dopamine D2 binding in depression
SHAH, P. J., OGILVIE, A. D., GOODWIN, G. M., & EBMEIER, K. P. (1997) · Psychological Medicine · doi:10.1017/s0033291797005382 · Cited by 170
Self-citation
Cited by
McKinnon, M. C., Yucel, K., Nazarov, A., & MacQueen, G. M. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0905 · Cited by 742
Lorenzetti, V., Allen, N. B., Fornito, A., & Yücel, M. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.021 · Cited by 553
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Recent developments and current controversies in depression
Ebmeier, K. P., Donaghey, C., & Steele, J. D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67964-6 · Cited by 434
Self-citationMaes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Konarski, J. Z., McIntyre, R. S., Kennedy, S. H., Rafi‐Tari, S., Soczynska, J. K., & Ketter, T. A. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00435.x · Cited by 299
Voxelwise meta-analysis of gray matter reduction in major depressive disorder
Du, M.-Y., Wu, Q.-Z., Yue, Q., Li, J., Liao, Y., Kuang, W.-H., Huang, X.-Q., Chan, R. C. K., Mechelli, A., & Gong, Q.-Y. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.09.014 · Cited by 237
“Studies which did not compare MDD patients with a healthy control group (Shah et al., 2002) or reporting no group differences in gray matter volume (Koolschijn et al.”
A cry in the dark: depressed mothers show reduced neural activation to their own infant’s cry
Laurent, H. K., & Ablow, J. C. (2012) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsq091 · Cited by 224
“SFG is also involved in effortful regulation of both positive and negative emotions (Mak et al., 2009), with deterioration related to depression severit (Shah et al., 2002).”
BackgroundOrbitofrontal volume reductions during emotion recognition in patients with major depression
Scheuerecker, J., Meisenzahl, E. M., Koutsouleris, N., Roesner, M., Schöpf, V., Linn, J., Wiesmann, M., Brückmann, H., Möller, H.-J., & Frodl, T. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090076 · Cited by 124
“Using voxel-based morphometry, Shah and colleagues(16) showed reduced grey matter density in the left temporal cortex in patients with chronic depression and changes in the left hippocampus in patients with treatment-resistant depression.(17) Right-sided hippocampal reductions(18) and significant bilateral reductions…”
Striatal structure and function in mood disorders: a comprehensive review
Marchand, W. R., & Yurgelun‐Todd, D. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00874.x · Cited by 91
Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression
Kim, Y.-K., & Na, K.-S. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.03.009 · Cited by 84
Can depression, anxiety and somatization be understood as appeasement displays?
Price, J. S., Gardner, R., & Erickson, M. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00452-4 · Cited by 70
Li, Z., Zhang, Y., Wang, Z., Chen, J., Fan, J., Guan, Y., Zhang, C., Yuan, C., Hong, W., Wang, Y., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.003 · Cited by 63
Prediction of antidepressant treatment response from gray matter volume across diagnostic categories
Sämann, P. G., Höhn, D., Chechko, N., Kloiber, S., Lucae, S., Ising, M., Holsboer, F., & Czisch, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.07.004 · Cited by 55
“Lower-than-normal hippocampal volumes have been observed early in chronic, treatment-resistant depression (Shah et al., 2002), and relatively lower hippocampal volumes at baseline were associated with poorer outcome over 8 weeks of antidepressant therapy (MacQueen et al., 2008) and after one (Frodl…”
Backgroundliu, Z., Guo, H., Cao, X., Cheng, C., Yang, C., Xu, C., Zhang, A., Sun, N., Li, X., & Zhang, K. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2014.05.010 · Cited by 50
Grieve, S. M., Korgaonkar, M. S., Etkin, A., Harris, A., Koslow, S. H., Wisniewski, S., Schatzberg, A. F., Nemeroff, C. B., Gordon, E., & Williams, L. M. (2013) · Trials · doi:10.1186/1745-6215-14-224 · Cited by 44
“Healthy control participants are extensively screened for the absence of Axis I disorders (using the MINI) and for an HRSD17 score 7.”
BackgroundMethodInfluentialQuest for biomarkers of treatment-resistant depression: Shifting the paradigm toward risk
Smith, D. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00057 · Cited by 22
Hoogenboom, W. S., Perlis, R. H., Smoller, J. W., Zeng-Treitler, Q., Gainer, V. S., Murphy, S. N., Churchill, S. E., Kohane, I. S., Shenton, M. E., & Iosifescu, D. V. (2013) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2012.07.007 · Cited by 13
Langenecker, S. A., Crane, N. A., Jenkins, L. M., Phan, K. L., & Klumpp, H. (2018) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-018-0140-2 · Cited by 11
Metadata
- Authors
- Shah, P. J., Glabus, M. F., Goodwin, G. M., & Ebmeier, K. P.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2002-05
- Volume
- 180
- Issue
- 5
- Pages
- 434-440
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2067317682
- Cited by
- 134
- References
- 7
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.